Supporting Women Who Struggle to Quit Smoking During Pregnancy: Why Evidence-Based Conversations Matter

Smoking during pregnancy remains one of the most significant preventable causes of adverse maternal and infant health outcomes worldwide. It increases the risk of miscarriage, placental complications, preterm birth, low birth weight, stillbirth, and sudden infant death syndrome, while also contributing to long-term health consequences for both mother and child. For healthcare professionals, the objective…

Regulatory Clarity Is Essential But So Is Proportionate Regulation

The rapid emergence of oral nicotine pouches has presented policymakers with a familiar challenge. Innovation is moving faster than legislation, forcing regulators to determine how new products fit within legal frameworks that were largely designed for traditional tobacco products decades ago. A recent editorial published in Addiction, “Novel Product, Familiar Challenges: Navigating Uncertainty in Oral…

New Oral Health Study Adds Important Evidence But Not the Final Answer on Nicotine Pouches

As tobacco-free nicotine pouches become more widely available, understanding their effects on oral health has become an important area of scientific research. Every new study contributes to a growing evidence base that should inform clinicians, regulators, and policymakers. A recently published study in Oral Diseases examined oral lesions and dental status among users of tobacco-free…

Beyond the Headlines: Why the Nicotine Pouch Debate Is Really About Risk, Not Nicotine

Recent commentary from researchers at Stanford University has reignited debate over nicotine pouches, describing them as the latest strategy by the tobacco industry to sustain nicotine addiction while raising concerns about youth appeal, flavours, marketing, and the absence of long-term health data. These concerns reflect genuine public health priorities and deserve careful consideration. However, the…

Brazil’s Nicotine Consultation: A Test Case for Evidence-Based Regulation

As governments around the world grapple with the rapid emergence of modern nicotine products, a common regulatory challenge is becoming increasingly apparent. How can policymakers protect public health while ensuring that regulation remains proportionate to the risks different products actually present? Brazil has become one of the latest countries to confront this question. The National…

The Hidden Smoking Burden Among People Who Use Drugs: Why Tobacco Harm Reduction Cannot Be Ignored

Public health discussions surrounding problematic drug use often focus on overdose prevention, infectious diseases, mental health, and access to treatment services. Yet one of the most significant contributors to illness and premature mortality among people who use drugs frequently receives far less attention: smoking. A recent briefing paper from the Global State of Tobacco Harm…

What Does the Science Say About Nicotine Pouches? Lower Toxicant Exposure, Remaining Uncertainties, and the Case for Proportionate Regulation

As nicotine pouches continue to expand across global markets, policymakers and public health stakeholders are increasingly asking important questions about their safety profile, long-term health implications, and appropriate regulation. A recent review published in Tobacco Induced Diseases, “Research on the Safety Risk of Oral Nicotine Products and Its Prospects,” contributes to this growing evidence base…

Tobacco products and tobacco advertising revision of EU rules

About GINN. The Global Institute for Novel Nicotine (GINN) is a membership-based association and the responsible voice of the novel nicotine sector. GINN represents small and medium-sized European manufacturers and distributors of nicotine pouches and promotes an evidence-based, science-led approach to the regulation of reduced-risk products, with the goal of helping adult smokers move away…

Beyond Endgame Thinking: What The Guardian Editorial and Palau’s UN Proposal Reveal About the Future of Nicotine Governance

Nicotine should be regulated proportionately to its risks and in a manner that accelerates the decline of combustible smoking. It should not be governed through sweeping “endgame” narratives that treat all nicotine products as though they occupy the same place on the risk spectrum. Recent interventions from both The Guardian and the Government of Palau…